Nursing Dilemmas in Chemotherapy-Induced Peripheral Neuropathy: A Qualitative Study of a Tertiary Hospital in China
Jia Xin Fan,Ya Chen Hu,XinXin Chen,YuMei Li
DOI: https://doi.org/10.2147/JPR.S409580
IF: 2.8319
2023-07-07
Journal of Pain Research
Abstract:Jia Xin Fan, 1, 2, &ast Ya Chen Hu, 1, 2, &ast XinXin Chen, 1, 2, &ast YuMei Li 2 1 School of Medicine, Tongji University, Shanghai, People's Republic of China; 2 Department of Nursing, Shanghai Pulmonary Hospital, Tongji University, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: YuMei Li, Department of Nursing, Shanghai Pulmonary Hospital, Tongji University, No. 507 Zheng Min Road, Shanghai, 200433, People's Republic of China, Tel +86 13917922290, Fax +86 021-65115006-2185, Email Purpose: This study investigated the experience of oncology nurses caring for chemotherapy-induced peripheral neuritis patients. Patients and Methods: Through phenomenological research method, 11 nurses in a tertiary hospital in Shanghai were interviewed using face-to-face semi-structured interviews. Data analysis was conducted with the thematic analysis approach. Results: This analysis revealed the experiences of oncology nurses in caring for patients with CIPN and identified three themes: 1) stress in the nursing of CIPN (inadequate knowledge of CIPN among oncology nurses, oncology nurses' CIPN nursing skills need to be improved, negative emotions of oncology nurses at work); 2) environmental dilemmas in nursing of CIPN (lack of effective care norms, busy schedules, doctors pay little attention to CIPN); 3) oncology nurses' desire to improve their knowledge of CIPN to meet care needs. Conclusion: Based on the perspective of oncology nurses, the care dilemma of CIPN is mainly influenced by individual and environmental factors. It is recommended to enhance the attention of oncology nurses to CIPN, set specific and feasible training courses, explore CIPN assessment tools that meet our clinical practice, and construct CIPN care programs to improve CIPN clinical care ability and reduce patient suffering. Keywords: lung cancer, nursing experience, qualitative research, qualitative study The World Health Organization (WHO) reports that cancer has become an important contributing factor to disease burdens. 1 Although chemotherapy technology has significantly prolonged cancer patient survival, it also causes a variety of long-term side effects, such as gastrointestinal reactions: nausea, vomiting, diarrhea; Bone marrow suppression: leukopenia, granulocyte, thrombocytopenia; Hair loss; Nephrotoxicity, hepatotoxicity, cardiotoxicity and neurotoxicity. 2–6 Patients who suffer from chemotherapy-induced peripheral neuropathy (CIPN) often stop treatment or have a poor prognosis as a result of this neurotoxic side effect. 7–9 CIPN is mainly manifested as numbness, tingling and paresthesia at the extremities, which is distributed in a "glove-sock" shape. 10 In severe cases, it will cause physical dysfunction, the risk of falls and self-care defects, and affect the quality of life of patients. 11 It has been reported that the incidence of CIPN in cancer patients can reach 68.1% in the first month after chemotherapy, 3 and more than 20–30% of patients will acquire chronic CIPN, with related symptoms lasting for half a year. 12 The factors closely related to the high incidence of CIPN are mainly divided into drug factors and individual factors. First of all, chemotherapeutic drugs can easily cause CIPN include taxanes, platinum drugs, proteasome inhibitors, vinca alkaloids and thalidomide, among which oxaliplatin (84%) 13 and paclitaxel (59–87%) 14 have the highest incidence of CIPN. Additionally, smoking, alcohol abuse, obesity, old age (>75 years), diabetes in the family or history of hereditary neuropathy, renal insufficiency, hypothyroidism, vitamin deficiency, human immunodeficiency virus (HIV) infection, autoimmune rheumatism, and underlying neuropathy all contribute to a high prevalence of CIPN. 15 Researchers have extensively studied epidemiology and management strategies for CIPN, primarily focusing on preventive medicine, 16–19 while the nursing is limited. Nurses play an important role in managing symptoms as disease caregivers. 20 It is reported that oncology nurses lack the knowledgeand the ability to manage CIPN. 21 The qualitative method allows the researcher to explore the essence through phenomena and is more likely to portray inner feelings. To provide a reference base for subsequent studies, this paper explores the experience of oncology nurses caring for CIPN patients, discussing hidden influencing factors. A purposive sampling method was used to select 11 oncology nurses from a tertiary hospital in Shanghai for s -Abstract Truncated-
clinical neurology